Delivery Order SPE2DX22D0010-SPE2D825FEW70

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $5.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,364.69, is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,454.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566400047 DEXMETHYLPHENIDATE ER CAPS 5MG, a pharmaceutical product, with a completion date of November 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,532.71 firm fixed price delivery order is for the supply of 4566384642 DEXMETHYLPHENIDATE ER CAPS 25MG, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,097.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a period of performance through February 5, 2025. This contract award is not associated with a set-aside designation....
This federal contract award, valued at $2,541.43, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559684887 - DEXMETHYLPHENIDATE ER CAPS 10MG, a prescription medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,229.07 and is for the delivery of DEXMETHYLPHENIDATE ER 5 MG CAP 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,196.45 Firm Fixed Price delivery order is for the supply of 4567756521 DEXMETHYLPHENIDATE ER 5 MG CAP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of April 2, 2025. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This award is part...
This federal contract award, valued at $5,789.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566623612 - DEXMETHYLPHENIDATE ER 20 MG CP 100S, with a completion date of December 6, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,788.02, is for the delivery of 4567502543 DEXMETHYLPHENIDATE ER 10 MG CP 100S. It is a Firm Fixed Price Delivery Order contract with a completion date of March 10, 2025. The contract was awarded on March 7, 2025 and has no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $2,467.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566746759 - DEXMETHYLPHENIDATE ER 10 MG CP 100S, with a completion date of December 18, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. No set-aside was used for this award. Amerisourcebergen holds significant Indefinite Delivery...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FEW70
    Delivery Order

This federal contract award, valued at $5,349.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567870529 - DEXMETHYLPHENIDATE ER CAPS 25MG. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies.

Generated 7/17/25, 6:12 PM